Stocks · News reference
OraSure Technologies reported its financial results for the third quarter ended September 30, 2026, highlighting 14% year-over-year revenue growth and improved gross margins.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
OraSure Technologies (NASDAQ:OSUR) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga
OraSure Technologies has joined the World Coalition on Sickle Cell Disease, an international public-private partnership focused on improving global care and early diagnosis for patients with the condition.
OraSure Technologies has joined the World Coalition on Sickle Cell Disease, a public-private international partnership aimed at strengthening the global fight against sickle cell disease. As a member, OraSure will contribute diagnostic expertise to support early diagnosis, screening, and improved healthcare system capacity to address patient needs in various healthcare settings.